Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Zhang, Yifan  [Clear All Filters]
Journal Article
Zhang Y, Chen Z, Ju Z, Hu Q. Assessment of Ferroptosis in Hematopoietic Stem and Progenitor Cells. Methods Mol Biol. 2023;2712:199-210.
Zhang Y, Li Z, Guo H, Wang Q, Guo B, Jiang X, Liu Y, Cui S, Wu Z, Yu M, et al. A Biomimetic Multifunctional Scaffold for Infectious Vertical Bone Augmentation. Adv Sci (Weinh). 2024:e2310292.
Shao L, Fang Q, Shi C, Zhang Y, Xia C, Zhang Y, Wang J, Chen F. Bone marrow mesenchymal stem cells inhibit ferroptosis via regulating the Nrf2-keap1/p53 pathway to ameliorate chronic kidney disease injury in the rats. J Recept Signal Transduct Res. 2023:1-10.
Zhang Y, Zheng L, Cheng D, Lei C, Li H, Zhou J, Zhang C, Song F, Zeng T, Zhao X. Chronic di(2-ethylhexyl) phthalate exposure at environmental-relevant doses induces osteoporosis by disturbing the differentiation of bone marrow mesenchymal stem cells. Sci Total Environ. 2024:169918.
Heng J, Shi B, Zhou J-Y, Zhang Y, Ma D, Yang Y-G, Liu F. Cpeb1b-mediated cytoplasmic polyadenylation of mRNA modulates zebrafish definitive hematopoiesis. Proc Natl Acad Sci U S A. 2023;120(7):e2212212120.
Liang G, Zhou C, Jiang X, Zhang Y, Huang B, Gao S, Kang Z, Ma D, Wang F, Göttgens B, et al. De novo generation of macrophage from placenta-derived hemogenic endothelium. Dev Cell. 2021.
O'Connell CD, Onofrillo C, Duchi S, Li X, Zhang Y, Tian P, Lu L, Trengove A, Quigley A, Gambhir S, et al. Evaluation of sterilisation methods for bio-ink components: gelatin, gelatin methacryloyl, hyaluronic acid and hyaluronic acid methacryloyl. Biofabrication. 2019.
Zhang Y, Liu F. The evolving views of hematopoiesis: from embryo to adulthood and from in vivo to in vitro. J Genet Genomics. 2023.
Lv P, Ma D, Gao S, Zhang Y, Bae Y-K, Liang G, Gao S, Choi J-H, Kim C-H, Wang L, et al. Generation of foxn1/Casper Mutant Zebrafish for Allograft and Xenograft of Normal and Malignant Cells. Stem Cell Reports. 2020.
Li N, Liu G, Gao H, Wu Q, Meng J, Wang F, Jiang S, Chen M, Xu W, Zhang Y, et al. Geriatric syndromes, chronic inflammation, and advances in the management of frailty: A review with new insights. Biosci Trends. 2023.
Zhang Y, Gao S, Xia J, Liu F. Hematopoietic Hierarchy - An Updated Roadmap. Trends Cell Biol. 2018.
Liu Y, Zhang Y, Mei T, Cao H, Hu Y, Jia W, Wang J, Zhang Z, Wang Z, Le W, et al. hESCs-Derived Early Vascular Cell Spheroids for Cardiac Tissue Vascular Engineering and Myocardial Infarction Treatment. Adv Sci (Weinh). 2022:e2104299.
Zhang Y, Liu F. Multidimensional Single-Cell Analyses in Organ Development and Maintenance. Trends Cell Biol. 2019.
Fu Z, Zhang Y, Geng X, Chi K, Liu C, Song C, Cai G, Chen X, Hong Q. Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury. Stem Cell Res Ther. 2023;14(1):116.
Wang B, Xie X, Jiang W, Zhan Y, Zhang Y, Guo Y, Wang Z, Guo N, Guo K, Sun J. Osteoinductive micro-nano guided bone regeneration membrane for in situ bone defect repair. Stem Cell Res Ther. 2024;15(1):135.
Zhou M, Shi W, Yu F, Zhang Y, Yu B, Tang J, Yang Y, Huang Y, Xiang Q, Zhang Q, et al. Pilot-scale expression, purification, and bioactivity of recombinant human TGF-β from Escherichia coli. Eur J Pharm Sci. 2018.
Heng J, Lv P, Zhang Y, Cheng X, Wang L, Ma D, Liu F. Rab5c-mediated endocytic trafficking regulates hematopoietic stem and progenitor cell development via Notch and AKT signaling. PLoS Biol. 2020;18(4):e3000696.
Zhang Y, Kang Z, Liu M, Wang L, Liu F. Single-cell omics identifies inflammatory signaling as a trans-differentiation trigger in mouse embryos. Dev Cell. 2024.
Ding Y, Wang W, Ma D, Liang G, Kang Z, Xue Y, Zhang Y, Wang L, Heng J, Zhang Y, et al. Smarca5 mediated epigenetic programming facilitates fetal HSPC development in vertebrates. Blood. 2020.
Jiang W, Zhan Y, Zhang Y, Sun D, Zhang G, Wang Z, Chen L, Sun J. Synergistic large segmental bone repair by 3D printed bionic scaffolds and engineered ADSC nanovesicles: Towards an optimized regenerative microenvironment. Biomaterials. 2024;308:122566.
Zhang Y, Li Y. β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase. Cancer Cell Int. 2024;24(1):121.